Patterson Financial Statements From 2010 to 2024
| PD2 Stock | EUR 29.40 0.40 1.34% |
Check Patterson Companies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Patterson Companies' main balance sheet or income statement drivers, such as , as well as many indicators such as . Patterson financial statements analysis is a perfect complement when working with Patterson Companies Valuation or Volatility modules.
Patterson |
Patterson Companies Company Return On Equity Analysis
Patterson Companies' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Patterson Companies Return On Equity | 0.19 |
Most of Patterson Companies' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Patterson Companies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Patterson Companies has a Return On Equity of 0.1927. This is 100.8% lower than that of the Healthcare sector and 97.41% lower than that of the Medical Distribution industry. The return on equity for all Germany stocks is 162.16% lower than that of the firm.
Patterson Companies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Patterson Companies's current stock value. Our valuation model uses many indicators to compare Patterson Companies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Patterson Companies competition to find correlations between indicators driving Patterson Companies's intrinsic value. More Info.Patterson Companies is regarded third in return on equity category among its peers. It is regarded fourth in return on asset category among its peers reporting about 0.26 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Patterson Companies is roughly 3.79 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Patterson Companies' earnings, one of the primary drivers of an investment's value.About Patterson Companies Financial Statements
Patterson Companies stakeholders use historical fundamental indicators, such as Patterson Companies' revenue or net income, to determine how well the company is positioned to perform in the future. Although Patterson Companies investors may analyze each financial statement separately, they are all interrelated. For example, changes in Patterson Companies' assets and liabilities are reflected in the revenues and expenses on Patterson Companies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Patterson Companies. Please read more on our technical analysis and fundamental analysis pages.
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. Patterson Companies, Inc. was founded in 1877 and is headquartered in St. PATTERSON COS operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 7800 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Patterson Stock
When determining whether Patterson Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Patterson Companies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Patterson Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Patterson Companies Stock:Check out the analysis of Patterson Companies Correlation against competitors. For more detail on how to invest in Patterson Stock please use our How to Invest in Patterson Companies guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.